Skip to main content

Prostate Biopsy: Ultrasound

  • Chapter
  • First Online:
Interventional Urology

Abstract

The transrectal ultrasound (TRUS) study of the prostate enhances patient care by providing a minimally invasive procedure that gives real-time information and feedback for rapid diagnosis or facilitating adjustment of diagnostic or therapeutic procedures. This chapter includes discussions of the prostate anatomy and embryologic development, the indications for TRUS, technical performance, and TRUS-guided biopsy and disease processes. The intent of the chapter is to assist the urologist or radiologist in maintaining a high degree of proficiency in performing, interpreting, and documenting the transrectal ultrasound study and biopsy of the prostate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kravchick S, Cytron S, Peled R, Altshuler A, Ben-Dor D. Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology. 2003;61(5):977–81.

    Article  PubMed  Google Scholar 

  2. Witjes WP, Aarinink RG, Ezz-el-Din K, Wijkstra H, Debruyne EM, de la Rosette JJ. The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms. Br J Urol. 1997;80(1):84–90.

    Article  CAS  PubMed  Google Scholar 

  3. Lim JW, Ko YT, Lee DH, Park SJ, Oh JH, Yoon Y, Chang SG. Treatment of prostatic abscess: value of transrectal ultrasonographically guided needle aspiration. J Ultrasound Med. 2000;19(9):609–17.

    Article  CAS  PubMed  Google Scholar 

  4. Etherington RJ, Clements R, Griffiths GJ, Peeling WB. Transrectal ultrasound in the investigation of haemospermia. Clin Radiol. 1990;41(3):175–7.

    Article  CAS  PubMed  Google Scholar 

  5. Worischeck JH, Parra RO. Chronic hematospermia: assessment by transrectal ultrasound. Urology. 1994;43(4):515–20.

    Article  CAS  PubMed  Google Scholar 

  6. Moore C, Karikehalli S, Nazeer T, Fisher HA, Kaufman RP Jr, Mian BM. Prognosis of high-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol. 2005;173(1):70–2.

    Article  PubMed  Google Scholar 

  7. Borboroglu P, Sur R, Roberts J, Amling C. Repeat biopsy strategy with atypical small acinar proliferation or high-grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol. 2001;166(3):866–70.

    Article  CAS  PubMed  Google Scholar 

  8. Scattoni V, Roscigno M, Raber M, Montorsi F, Da Pozzo L, Guazzoni G, Freschi M, Rigatti P. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive role of TRUS, DRE, PSA and the pathological stage. Eur Urol. 2003;44(4):407–14.

    Article  PubMed  Google Scholar 

  9. Deliveliotis C, Manousakas T, Chrisofos M, Skolarikos A, Delis A, Dimopoulos C. Diagnostic efficacy of ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy. World J Urol. 2007;25(3):309–13.

    Article  PubMed  Google Scholar 

  10. Frauscher F, Klauser A, Volgger H, Halpern EJ, Pallwein L, Steiner H, Schuster A, Horninger W, Rogatsch H, Bartsch G. Comparison of contrast-enhanced color Doppler-targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol. 2002;167(4):1648–52.

    Article  PubMed  Google Scholar 

  11. Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol. 2000;163(4):1144–9.

    Article  CAS  PubMed  Google Scholar 

  12. Fowler J, Bigler S, Miles D, Yalkut D. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol. 2000;163(3):813–8.

    Article  PubMed  Google Scholar 

  13. Ghani K, Rockall A, Nargund V, Chinegwundoh F. Prostate biopsy: to stop anticoagulation or not? BJU Int. 2006;97(2):224–5.

    Article  PubMed  Google Scholar 

  14. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound-guided prostate needle biopsy: a prospective study and review of the literature. J Urol. 1998;160(6 pt 1):2115–20.

    CAS  PubMed  Google Scholar 

  15. Maan Z, Cutting CW, Patel U, Kerry S, Pietrzak P, Perry MJ, Kirby RS. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int. 2003;91(9):798–800.

    Article  CAS  PubMed  Google Scholar 

  16. AUA. The prevention and treatment of the more common complications related to prostate biopsy [Internet]. 2012 [updated 2016; cited 2018 Dec 21]. Available from: https://www.auanet.org/guidelines/prostate-needle-biopsy-complications.

  17. Zani EL, Clark OA, Rodrigues Netto N Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. 2011;5:CD006576.

    Google Scholar 

  18. Rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology. 2003;62(3):461–6.

    Google Scholar 

  19. Lindert K, Kabalin J, Terris M. Bacteremia and bacteriuria after transrectal ultrasound-guided prostate biopsy. J Urol. 2000;164(1):76–80.

    Article  CAS  PubMed  Google Scholar 

  20. Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, Colon I. The incidence of fluoroquinolone-resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J Urol. 2008;179(3):952–5.

    Article  PubMed  Google Scholar 

  21. Liss MA, Taylor SA, Batura D, Steensels D, Chayakulkeeree M, Soenens C, et al. Fluoroquinolone-resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol. 2014;192(6):1673–8.

    Article  PubMed  Google Scholar 

  22. Roberts MJ, Williamson DA, Hadway P, Doi SA, Gardiner RA, Paterson DL. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. Int J Antimicrob Agents. 2014;43(4):301–9.

    Article  CAS  PubMed  Google Scholar 

  23. Patel U, Dasgupta P, Amoroso P, Challacombe B, Pilcher J, Kirby R. Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int. 2012;109(12):1781–5.

    Article  PubMed  Google Scholar 

  24. Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol. 2012;187(4):1275–9.

    Article  CAS  PubMed  Google Scholar 

  25. Duplessis CA, Bavaro M, Simons MP, Marguet C, Santomauro M, Auge B, et al. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology. 2012;79(3):556–61.

    Article  PubMed  Google Scholar 

  26. Liss MA, Chang A, Santos R, Nakama-Peeples A, Peterson EM, Osann K, et al. Prevalence and significance of fluoroquinolone-resistant Escherichia coli in patients undergoing transrectal ultrasound-guided prostate needle biopsy. J Urol. 2011;185(4):1283–8.

    Article  PubMed Central  PubMed  Google Scholar 

  27. AUA. Urologic surgery antimicrobial prophylaxis [Internet]. 2008 [updated 2012; cited 2018 Dec 21]. Available from: https://www.auanet.org/guidelines/antimicrobial-prophylaxis-(2008-reviewed-and-validity-confirmed-2011-amended-2012).

  28. Symons JL, Huo A, Yuen CL, Haynes AM, Matthews J, Sutherland RL, Brenner P, Stricker PD. Outcomes of transperineal template-guided prostate biopsy in 409 patients. BJU Int. 2013;112(5):585–93.

    Article  CAS  PubMed  Google Scholar 

  29. AUA/SUNA. AUA/SUNA white paper on the incidence, prevention and treatment of complications related to prostate needle biopsy [Internet]. 2012 [cited 2018 Dec 21]. Available from: https://www.suna.org/resource/white-paper-incidence-prevention-and-treatment-complications-related-prostate-needle-biopsy.

  30. Kravchick S, Peled R, Ben-Dor D, Dorfman D, Kesari D, Cytron S. Comparison of different local anesthesia techniques during TRUS-guided biopsies: a prospective pilot study. Urology. 2005;65(1):109–13.

    Article  PubMed  Google Scholar 

  31. Taverna G, Maffezzini M, Benetti A, Seveso M, Giusti G, Graziotti P. A single injection of lidocaine as local anesthesia for ultrasound-guided needle biopsy of the prostate. J Urol. 2002;167(1):222–3.

    Article  PubMed  Google Scholar 

  32. Cevik I, Dillioglugil O, Zisman A, Akdas A. Combined “periprostatic and periapical” local anesthesia is not superior to “periprostatic” anesthesia alone in reducing pain during tru-cut prostate biopsy. Urology. 2006;68(6):1215–9.

    Article  PubMed  Google Scholar 

  33. Lee H, Lee H, Byun S, Lee SE, Hong SK, Kim SH. Effect of intraprostatic local anesthesia during transrectal ultrasound-guided prostate biopsy: comparison of 3 methods in a randomized, double-blind, placebo controlled trial. J Urol. 2007;178(2):469–72.

    Article  CAS  PubMed  Google Scholar 

  34. Kravchick S, Cytron S, Peled R, London D, Sibi Y, Ben-Dor D. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies. Urology. 2004;63(2):301–5.

    Article  PubMed  Google Scholar 

  35. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound-guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159(2):471–5.

    Article  CAS  PubMed  Google Scholar 

  36. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, et al. A comparative analysis of sextant and an extended 11-core multisite-directed biopsy strategy. J Urol. 2000;163(1):152–7.

    Article  CAS  PubMed  Google Scholar 

  37. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int. 2002;89(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  38. Lughezzani G, Sun M, Budaus L, Thuret R, Shariat SF, Perrotte P, Karakiewicz PI. Effect of the number of biopsy cores on prostate cancer detection and staging. Future Oncol. 2010;6(3):381–90.

    Article  PubMed  Google Scholar 

  39. Chrouser KL, Lieber MM. Extended and saturation needle biopsy for the diagnosis of prostate cancer. Curr Urol Rep. 2004;5(3):226–30.

    Article  PubMed  Google Scholar 

  40. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, et al. American urological association. Prostate-specific antigen best practice statement: 2009 update. J Urol. 2009;182(5):2232–41.

    Article  CAS  PubMed  Google Scholar 

  41. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer early detection [Internet]. 2018 [updated 2018 Apr 5; cited 2018 Dec 21]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf.

  42. Hodge K, McNeal J, Terris M, Stamey T. Random systematic versus directed ultrasound -guided transrectal core biopsies of the prostate. J Urol. 1989 Jul;142(1):71–4.

    Article  CAS  PubMed  Google Scholar 

  43. Remzi M, Fong Y, Dobrovits M, Anagnostou T, Seitz C, Waldert M, et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005;174(4):1256–60.

    Article  PubMed  Google Scholar 

  44. Renfer L, Schow D, Thompson I, Optenberg S. Is ultrasound guidance necessary for transrectal prostate biopsy? J Urol. 1995;154(4):1390–1.

    Article  CAS  PubMed  Google Scholar 

  45. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol. 2004;171(3):1089–92.

    Article  PubMed  Google Scholar 

  46. Igel T, Knight M, Young P, Wehle MJ, Petrou SP, Broderick GA, et al. Systematic transperineal ultrasound-guided template biopsy of the prostate in patients at high risk. J Urol. 2001;165(5):1575–9.

    Article  CAS  PubMed  Google Scholar 

  47. Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS. Saturation technique does not decrease cancer detection during follow-up after initial prostate biopsy. J Urol. 2008;179(5):1746–50.

    Article  PubMed  Google Scholar 

  48. Nelson E, Slotoroff C, Gomeela L, Halpern E. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007;70(6):1136–40.

    Article  PubMed  Google Scholar 

  49. Brock M, von Brodman C, Palisaar R, Löppenberg B, Sommerer F, Deix T, et al. The impact of real-time elastography guiding a systematic prostate biopsy to improve detection rate: a prospective study of 353 patients. J Urol. 2012;187(6):2039–43.

    Article  PubMed  Google Scholar 

  50. Aigner F, Pallwein L, Junker D, Schäfer G, Mikuz G, Pedross F, et al. Value of real-time elastography-targeted biopsy for prostate cancer detection in men with prostate-specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less. J Urol. 2010;184(3):913–7.

    Article  PubMed  Google Scholar 

  51. Pokorny MR, de Rooij M, Duncan E, Schröder FH, Parkinson R, Barentsz JO, Thompson LC. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol. 2014;66(1):22–9.

    Article  PubMed  Google Scholar 

  52. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378(19):1767–77.

    Article  PubMed  Google Scholar 

  53. Pepdjonovic L, Tan GH, Huang S, Mann S, Frydenberg M, Moon D, et al. Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol. 2017;35(8):1199–203.

    Article  CAS  PubMed  Google Scholar 

  54. Takenaka A, Hara R, Ishimura T, Fujii T, Jo Y, Nagai A, Fujisawa M. A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostatic Dis. 2008;11(2):134–8.

    Article  CAS  PubMed  Google Scholar 

  55. Mabjeesh NJ, Lidawi G, Chen J, German L, Matzkin H. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int. 2012;110(7):993–7.

    Article  PubMed  Google Scholar 

  56. Altman A, Resnick M. Ultrasonographically guided biopsy of the prostate gland. J Ultrasound Med. 2001;20(2):159–67.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lao, M., Fulgham, P.F., Gilbert, B.R. (2021). Prostate Biopsy: Ultrasound. In: Rastinehad, A.R., Siegel, D.N., Wood, B.J., McClure, T. (eds) Interventional Urology . Springer, Cham. https://doi.org/10.1007/978-3-030-73565-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-73565-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-73564-7

  • Online ISBN: 978-3-030-73565-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics